For this meeting, the Working Group will 1) hear presentations from eight subcommittees on their findings and potential actions for the TBDWG to consider; 2) hear updates from the Public Comment and Inventory Subcommittees; and 3) further discuss plans for developing the 2020 report to the HHS Secretary and Congress on federal tick-borne activities and research.

The meeting will be held at the Hyatt Place Washington DC/US Capitol, 33 New York Avenue NE, Washington, DC 20002.

In-person attendance at the meeting is limited to space available. Therefore, preregistration for public members is advisable and can be accomplished by registering here exit disclaimer icon.

Members of the public may also attend the meeting via webcast. Instructions for attending via webcast will be posted about one week prior to the meeting.

Federal Register Meeting Notice

Public Comment – Information and Instructions

The public will have an opportunity to present their views to the Working Group during the meeting’s public comment session or by submitting their views in writing.

Verbal comments (in-person):

  • Requests to provide verbal public comment must be submitted via email by midnight Tuesday, January 17, 2020, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Verbal Public Comment – January 28-29 Meeting. In addition, please indicate if you will be providing verbal comment in person or by phone. If by phone, you will be provided a call-in number and and time to call.
  • A total of 30 minutes has been set aside for verbal comments on both days. Each person will be limited to 3 minutes in order to accommodate as many speakers as possible. If more requests are received than can be accommodated, speakers will be randomly selected.
  • Your remarks will be heard over a live webcast and will become part of the archived recording and meeting summary that will be posted on this website.

Written comments (posted on this webpage and accessible to the public):

    • Written public comments must be submitted via email by midnight Tuesday, January 17, 2020, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Written Public Comment – January 28-29 Meeting.
    • When you submit your written comment, please include a statement letting us know how you would like to be identified with your comment. You may choose to use your name or to be anonymous. You may also list your city and/or state. If you are providing comments on behalf of an organization, please include the name of the organization. We cannot post your comment until you let us know how you would like to be identified.
    • Comments should either be provided in the body of your email, or in an attachment in Word format and equivalent to no more than 4 pages in Calibri or Times New Roman, 11 point font. Text that exceeds the 4 pages will be deleted.
    • We do not post graphics, images, text boxes, or tables. If included with your comment, we will not be able to retain them.
    • We can only create hyperlinks to “.gov” sites (local, state, or federal). For all other reference sites, please insert the full URL (e.g., http://learn.genetics.utah.edu/content/epigenetics exit disclaimer icon).
    • We are also unable to include attachments as supporting documentation to your written comments.

Click here for more information about the TBDWG.